Open-mkt buys · 90d
$40.0K
1 trades · 1 insiders
Open-mkt sales · 90d
$131.32M
30 trades · 5 insiders
Net · 90d
$-131.28M
Insiders on file
65
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kerr Douglas | Head of R&D and CMO | 23 | $0 | $482.2K | 2026-10-20 |
| Posner Brian S | Director | 10 | $314.8K | $0 | 2026-10-02 |
| Friedl-Naderer Johanna | Chief Commercial Officer | 21 | $0 | $92.2K | 2026-09-08 |
| Cox John | See Remarks | 30 | $1.97M | $819.2K | 2026-09-08 |
| Rhodes Jason P | Director | 132 | $10.00M | $238.54M | 2026-08-14 |
| Lucera Erick | Chief Financial Officer | 9 | $0 | $275.9K | 2026-08-13 |
| Kersten Dirk | Director, 10% Owner | 109 | $50.24M | $150.85M | 2026-07-27 |
| Greene Barry E | Director | 1 | $0 | $0 | 2026-06-22 |
| Incerti Carlo | Director | 8 | $0 | $474.0K | 2026-06-05 |
| Stehman-Breen Catherine | Director | 12 | $100.0K | $0 | 2026-06-05 |
| Lubner David Charles | Director | 13 | $499.8K | $0 | 2026-06-05 |
| HURWITZ EDWARD | Director, 10% Owner | 21 | $9.25M | $0 | 2026-06-05 |
| Karnani Vikram | Director | 1 | $0 | $0 | 2025-12-22 |
| Beskrovnaya Oxana | See Remarks | 52 | $0 | $3.50M | 2025-03-11 |
| Scalzo Richard William | See Remarks | 83 | $0 | $8.71M | 2025-03-11 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 54 | $0 | $8.47M | 2024-09-18 |
| Farwell Wildon | Chief Medical Officer | 31 | $0 | $955.5K | 2024-08-19 |
| McNeill Jonathan | See Remarks | 66 | $0 | $5.63M | 2024-08-19 |
| Brumm Joshua T | See Remarks | 80 | $0 | $26.68M | 2024-03-11 |
| Atlas Venture Associates Opportunity II, LP | 10% Owner | 2 | $0 | $1.40M | 2024-03-01 |
| Atlas Venture Associates XI, L.P. | 10% Owner | 23 | $0 | $31.49M | 2024-02-28 |
| Atlas Venture Associates XI, LLC | 10% Owner | 6 | $0 | $11.34M | 2024-02-23 |
| Atlas Venture Opportunity Fund II, L.P. | 10% Owner | 1 | $10.00M | $0 | 2022-12-12 |
| Klein Lawrence Otto | Director | 8 | $100.0K | $0 | 2022-07-05 |
| Atlas Venture Fund XI, L.P. | 10% Owner | 1 | $0 | $0 | 2021-07-13 |
| CureDuchenne Ventures, LLC | 10% Owner | 2 | $0 | $0 | 2020-09-21 |
| VV Manager II, LLC | 10% Owner | 6 | $15.48M | $0 | 2020-09-21 |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 3 | $0 | $0 | 2020-09-21 |
| Logos Global Management LP | 10% Owner | 3 | $13.30M | $0 | 2020-09-21 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 2 | $0 | $0 | 2020-09-21 |
| Atlas Venture Associates Opportunity I, LLC | 10% Owner | 4 | $0 | $0 | 2020-09-21 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | 10% Owner | 9 | $0 | $0 | 2020-09-21 |
| Kolchinsky Peter | 10% Owner | 3 | $12.54M | $0 | 2020-09-21 |
| Subramanian Romesh | Chief Scientific Officer | 2 | $0 | $0 | 2020-09-17 |
| Ellis Dean | Senior Vice President | 18 | $0 | $0 | 2018-04-09 |
| Daley Martin W. | Executive Vice President | 39 | $49.4K | $0 | 2018-04-09 |
| Cox Julius | Executive Vice President | 32 | $24.9K | $0 | 2018-04-09 |
| Petrone Sheree M. | Executive Vice President | 25 | $77.3K | $0 | 2018-04-09 |
| Jones Henry D. | EVP and Chief Commercial Off. | 34 | $77.7K | $0 | 2018-04-09 |
| Stein Jeffrey Scott | Director | 8 | $24.7K | $0 | 2018-04-09 |
| Ackermann Hilary E. | Director | 9 | $26.2K | $0 | 2018-04-09 |
| Walden John Clinton | VP and Chief Acct Officer | 52 | $0 | $0 | 2018-04-09 |
| James Catherine C. | Exec VP and General Counsel | 47 | $61.0K | $0 | 2018-04-09 |
| Kuersteiner Richard Lee | Director | 22 | $353.0K | $0 | 2018-04-09 |
| Freeland Clint | Exec. VP and CFO | 49 | $203.5K | $0 | 2018-04-09 |
| Burke Carolyn Jeanne | EVP, Strategy | 47 | $77.0K | $0 | 2018-04-09 |
| Wood Patrick III | Director | 11 | $336.2K | $0 | 2018-04-09 |
| SULT JOHN R | Director | 8 | $249.1K | $0 | 2018-04-09 |
| FLEXON ROBERT C | President and CEO | 58 | $1.84M | $0 | 2018-04-09 |
| BARBAS PAUL M | Director | 8 | $100.0K | $0 | 2018-04-09 |
| Terawatt Holdings GP, LLC | 10% Owner | 1 | $0 | $61.90M | 2018-01-09 |
| Alonso Mario E | VP-Strategic Planning & Dev | 54 | $50.0K | $0 | 2016-04-01 |
| Thompson Daniel P. | EVP | 6 | $17.6K | $0 | 2016-03-18 |
| FRANKLIN RESOURCES INC | 10% Owner | 153 | $0 | $648.63M | 2015-06-02 |
| Howell Kevin | Exec VP and COO | 9 | $0 | $0 | 2012-10-31 |
| ELWARD THOMAS W | Director | 10 | $0 | $0 | 2012-10-02 |
| MERKSAMER SAMUEL J. | Other | 7 | $0 | $0 | 2012-10-01 |
| ICAHN CAPITAL LP | 10% Owner | 2 | $0 | $0 | 2012-10-01 |
| INTRIERI VINCENT J | Other | 7 | $0 | $0 | 2012-10-01 |
| PARDO FELIX | Director | 7 | $0 | $0 | 2012-10-01 |
| EMBLER MICHAEL J | Director | 10 | $0 | $0 | 2012-10-01 |
| LITESPEED MASTER FUND, LTD. | 10% Owner | 14 | $6.86M | $0 | 2012-07-03 |
| Litespeed Management, L.L.C. | 10% Owner | 2 | $540.9K | $0 | 2012-06-29 |
| ZIMMERMAN, JAMIE | 10% Owner | 3 | $364.5K | $0 | 2012-06-27 |
| Stone Carolyn J | SVP, Chief Accounting Officer | 6 | $0 | $0 | 2012-03-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kerr Douglas | Head of R&D and CMO | A Award deriv | 2026-10-20 | 2026-10-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Kerr Douglas | Head of R&D and CMO | A Award | 2026-10-20 | 2026-10-22 | 8,000 | — | $0 | 170,564 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-10-02 | 2026-10-06 | 2,500 | $16.00 | $40.0K | 27,000 | SEC↗ |
| Cox John | CEO & President | S Sale | 2026-09-08 | 2026-09-08 | 5,658 | $18.88 | $106.8K | 357,507 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-09-08 | 2026-09-08 | 1,290 | $18.88 | $24.4K | 162,564 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-09-08 | 2026-09-08 | 185 | $18.88 | $3.5K | 152,897 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-09-08 | 2026-09-08 | 185 | $18.88 | $3.5K | 152,897 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-09-08 | 2026-09-08 | 1,290 | $18.88 | $24.4K | 162,564 | SEC↗ |
| Cox John | CEO & President, Director | S Sale | 2026-09-08 | 2026-09-08 | 5,658 | $18.88 | $106.8K | 357,507 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-09-04 | 2026-09-08 | 3,745 | $24.35 | $91.2K | 163,854 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-09-04 | 2026-09-08 | 900 | $24.35 | $21.9K | 153,082 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-09-04 | 2026-09-08 | 900 | $24.35 | $21.9K | 153,082 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-09-04 | 2026-09-08 | 3,745 | $24.35 | $91.2K | 163,854 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 322,465 | $25.00 | $8.06M | 428,946 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 478,377 | $25.00 | $11.96M | 567,358 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 1,359,674 | $25.00 | $33.99M | 2,441,454 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 322,465 | $25.00 | $8.06M | 428,946 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 478,377 | $25.00 | $11.96M | 567,358 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-14 | 2026-08-17 | 1,359,674 | $25.00 | $33.99M | 2,441,454 | SEC↗ |
| Lucera Erick | Chief Financial Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,797 | $26.28 | $47.2K | 119,766 | SEC↗ |
| Cox John | CEO & President | S Sale | 2026-08-13 | 2026-08-17 | 4,986 | $26.28 | $131.0K | 363,165 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,556 | $26.28 | $40.9K | 167,599 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-08-13 | 2026-08-17 | 226 | $26.28 | $5.9K | 153,982 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 63,643 | $26.20 | $1.67M | 751,411 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 94,415 | $26.20 | $2.47M | 1,045,735 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 268,354 | $26.20 | $7.03M | 3,801,128 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-08-13 | 2026-08-17 | 226 | $26.28 | $5.9K | 153,982 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,556 | $26.28 | $40.9K | 167,599 | SEC↗ |
| Lucera Erick | Chief Financial Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,797 | $26.28 | $47.2K | 119,766 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 63,643 | $26.20 | $1.67M | 751,411 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 94,415 | $26.20 | $2.47M | 1,045,735 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-08-13 | 2026-08-17 | 268,354 | $26.20 | $7.03M | 3,801,128 | SEC↗ |
| Cox John | CEO & President, Director | S Sale | 2026-08-13 | 2026-08-17 | 4,986 | $26.28 | $131.0K | 363,165 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-07-27 | 2026-07-29 | 256,072 | $25.50 | $6.53M | 3,592,184 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-07-27 | 2026-07-29 | 5,388 | $26.04 | $140.3K | 3,586,796 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-07-27 | 2026-07-29 | 5,388 | $26.04 | $140.3K | 3,586,796 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-07-27 | 2026-07-29 | 256,072 | $25.50 | $6.53M | 3,592,184 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 5,000 | $23.61 | $118.0K | 2,962 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 124,379 | $23.17 | $2.88M | 4,099,069 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 29,587 | $23.62 | $698.8K | 4,069,482 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 11,665 | $23.62 | $275.5K | 815,054 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 49,193 | $23.17 | $1.14M | 826,719 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 14,844 | $23.62 | $350.6K | 1,140,150 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-07 | 2026-07-08 | 62,543 | $23.17 | $1.45M | 1,154,994 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-06 | 2026-07-08 | 100,019 | $22.79 | $2.28M | 875,912 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-06 | 2026-07-08 | 253,039 | $22.79 | $5.77M | 4,223,448 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-07-06 | 2026-07-08 | 127,182 | $22.79 | $2.90M | 1,217,537 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-29 | 2026-06-30 | 51,756 | $21.14 | $1.09M | 1,344,719 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-29 | 2026-06-30 | 40,702 | $21.14 | $860.4K | 975,931 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-29 | 2026-06-30 | 102,969 | $21.14 | $2.18M | 4,476,487 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-26 | 2026-06-30 | 64,411 | $21.28 | $1.37M | 1,016,633 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-26 | 2026-06-30 | 81,903 | $21.28 | $1.74M | 1,396,475 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-26 | 2026-06-30 | 162,954 | $21.28 | $3.47M | 4,579,456 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-25 | 2026-06-26 | 5,019 | $21.10 | $105.9K | 1,081,044 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-25 | 2026-06-26 | 12,699 | $21.10 | $267.9K | 4,742,410 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-25 | 2026-06-26 | 6,382 | $21.10 | $134.7K | 1,478,378 | SEC↗ |
| Lucera Erick | Chief Financial Officer | S Sale | 2026-06-25 | 2026-06-26 | 2,362 | $20.37 | $48.1K | 121,563 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-24 | 2026-06-26 | 50,530 | $21.02 | $1.06M | 4,755,109 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-24 | 2026-06-26 | 25,397 | $21.02 | $533.8K | 1,484,760 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-24 | 2026-06-26 | 19,973 | $21.02 | $419.8K | 1,086,063 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-06-23 | 2026-06-24 | 71,629 | $21.04 | $1.51M | 3,849,913 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-06-23 | 2026-06-24 | 1,657 | $21.47 | $35.6K | 3,848,256 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-23 | 2026-06-26 | 39,131 | $21.13 | $826.8K | 1,510,157 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-23 | 2026-06-26 | 77,855 | $21.13 | $1.65M | 4,805,639 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-06-23 | 2026-06-26 | 30,774 | $21.13 | $650.3K | 1,106,036 | SEC↗ |
| Greene Barry E | Director | A Award deriv | 2026-06-22 | 2026-06-23 | 57,463 | — | $0 | 57,463 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-06-22 | 2026-06-24 | 190,676 | $20.57 | $3.92M | 3,921,542 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-06-18 | 2026-06-22 | 46,901 | $20.07 | $941.3K | 4,112,218 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-06-17 | 2026-06-22 | 37,454 | $20.14 | $754.3K | 4,159,119 | SEC↗ |
| Cox John | CEO & President | S Sale | 2026-06-16 | 2026-06-17 | 2,683 | $18.33 | $49.2K | 368,151 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-06-16 | 2026-06-17 | 145 | $18.33 | $2.7K | 154,208 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-06-16 | 2026-06-17 | 887 | $18.33 | $16.3K | 169,155 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-06-08 | 2026-06-09 | 2,000 | $16.94 | $33.9K | 24,500 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Incerti Carlo | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Kersten Dirk | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Rhodes Jason P | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-06-03 | 2026-06-05 | 2,500 | $17.48 | $43.7K | 22,500 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-05-26 | 2026-05-28 | 2,000 | $18.21 | $36.4K | 20,000 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-05-20 | 2026-05-22 | 2,500 | $17.12 | $42.8K | 18,000 | SEC↗ |
| Cox John | CEO & President | S Sale | 2026-05-13 | 2026-05-14 | 3,311 | $18.36 | $60.8K | 370,834 | SEC↗ |
| Lucera Erick | Chief Financial Officer | S Sale | 2026-05-13 | 2026-05-14 | 1,448 | $18.36 | $26.6K | 123,925 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-05-13 | 2026-05-14 | 1,564 | $18.36 | $28.7K | 170,042 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-05-13 | 2026-05-14 | 228 | $18.36 | $4.2K | 154,353 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-06 | 2026-05-06 | 17,244 | $18.18 | $313.5K | 1,136,810 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-06 | 2026-05-06 | 428 | $18.18 | $7.8K | 7,962 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-06 | 2026-05-06 | 43,621 | $18.18 | $793.0K | 4,883,494 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-06 | 2026-05-06 | 21,926 | $18.18 | $398.6K | 1,549,288 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-05 | 2026-05-06 | 2,403 | $18.03 | $43.3K | 1,154,054 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-05 | 2026-05-06 | 60 | $18.03 | $1.1K | 8,390 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-05 | 2026-05-06 | 6,081 | $18.03 | $109.6K | 4,927,115 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-05 | 2026-05-06 | 3,056 | $18.03 | $55.1K | 1,571,214 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-04 | 2026-05-06 | 6,241 | $18.00 | $112.3K | 4,933,196 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-04 | 2026-05-06 | 3,136 | $18.00 | $56.4K | 1,574,270 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-04 | 2026-05-06 | 2,466 | $18.00 | $44.4K | 1,156,457 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-05-04 | 2026-05-06 | 61 | $18.00 | $1.1K | 8,450 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 119,115 | $18.38 | $2.19M | 4,939,489 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 59,870 | $18.38 | $1.10M | 1,577,432 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 21 | $19.00 | $399 | 1,158,923 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 1,170 | $18.38 | $21.5K | 8,512 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 47,082 | $18.38 | $865.4K | 1,158,944 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 1 | $19.00 | $19 | 8,511 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 52 | $19.00 | $988 | 4,939,437 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-28 | 2026-04-30 | 26 | $19.00 | $494 | 1,577,406 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-27 | 2026-04-27 | 894 | $18.15 | $16.2K | 9,682 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-27 | 2026-04-27 | 35,947 | $18.15 | $652.4K | 1,206,026 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-27 | 2026-04-27 | 90,943 | $18.15 | $1.65M | 5,058,604 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-27 | 2026-04-27 | 45,709 | $18.15 | $829.6K | 1,637,302 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-24 | 2026-04-27 | 36,345 | $18.48 | $671.7K | 1,683,011 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-24 | 2026-04-27 | 28,583 | $18.48 | $528.2K | 1,241,973 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-24 | 2026-04-27 | 710 | $18.48 | $13.1K | 10,576 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-24 | 2026-04-27 | 72,310 | $18.48 | $1.34M | 5,149,547 | SEC↗ |
| Lubner David Charles | Director | G Gift | 2026-04-24 | 2026-04-28 | 53,625 | — | $0 | 0 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-23 | 2026-04-27 | 19,261 | $19.19 | $369.6K | 1,719,356 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-23 | 2026-04-27 | 38,322 | $19.19 | $735.4K | 5,221,857 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-23 | 2026-04-27 | 377 | $19.19 | $7.2K | 11,286 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-23 | 2026-04-27 | 15,148 | $19.19 | $290.7K | 1,270,556 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-22 | 2026-04-22 | 75,866 | $19.68 | $1.49M | 1,738,617 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-22 | 2026-04-22 | 150,942 | $19.68 | $2.97M | 5,260,179 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-22 | 2026-04-22 | 1,485 | $19.68 | $29.2K | 11,663 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-22 | 2026-04-22 | 59,663 | $19.68 | $1.17M | 1,285,704 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-22 | 2026-04-23 | 2,652 | $20.00 | $53.0K | 4,196,573 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 605 | $20.05 | $12.1K | 1,345,367 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 71,499 | $19.51 | $1.39M | 1,815,252 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 142,253 | $19.51 | $2.78M | 5,412,651 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 1,398 | $19.51 | $27.3K | 13,163 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 56,228 | $19.51 | $1.10M | 1,345,972 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 769 | $20.05 | $15.4K | 1,814,483 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 1,530 | $20.05 | $30.7K | 5,411,121 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-21 | 2026-04-22 | 15 | $20.05 | $301 | 13,148 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-21 | 2026-04-23 | 8,300 | $20.01 | $166.1K | 4,199,225 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-20 | 2026-04-21 | 125,274 | $20.07 | $2.51M | 4,207,525 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-20 | 2026-04-22 | 71,676 | $20.06 | $1.44M | 1,886,751 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-20 | 2026-04-22 | 142,604 | $20.06 | $2.86M | 5,554,904 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-20 | 2026-04-22 | 1,401 | $20.06 | $28.1K | 14,561 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2026-04-20 | 2026-04-22 | 56,368 | $20.06 | $1.13M | 1,402,200 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-17 | 2026-04-21 | 211,974 | $20.29 | $4.30M | 4,332,799 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-16 | 2026-04-17 | 11,116 | $21.10 | $234.5K | 4,551,430 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-16 | 2026-04-17 | 6,657 | $20.06 | $133.5K | 4,544,773 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-04-15 | 2026-04-17 | 81,840 | $20.27 | $1.66M | 4,562,546 | SEC↗ |
| Lucera Erick | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-03 | 5,727 | $18.64 | $106.8K | 125,373 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-03-30 | 2026-04-01 | 2,000 | $17.08 | $34.2K | 15,500 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-03-11 | 2026-03-13 | 129,672 | $19.52 | $2.53M | 4,644,386 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-03-11 | 2026-03-13 | 2,000 | $19.35 | $38.7K | 13,500 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-03-10 | 2026-03-11 | 219,758 | $19.33 | $4.25M | 5,055,916 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-03-10 | 2026-03-11 | 9,482 | $18.21 | $172.7K | 5,275,674 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-03-10 | 2026-03-11 | 281,858 | $19.80 | $5.58M | 4,774,058 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2026-03-09 | 2026-03-11 | 177,690 | $17.72 | $3.15M | 5,285,156 | SEC↗ |
| Posner Brian S | Director | P Buy | 2026-03-06 | 2026-03-10 | 3,000 | $15.06 | $45.2K | 11,500 | SEC↗ |
| Cox John | CEO & President | S Sale | 2026-03-05 | 2026-03-06 | 2,732 | $14.90 | $40.7K | 374,145 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2026-03-05 | 2026-03-06 | 904 | $14.90 | $13.5K | 171,606 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2026-03-05 | 2026-03-06 | 148 | $14.90 | $2.2K | 154,581 | SEC↗ |
| Lucera Erick | Chief Financial Officer | A Award deriv | 2026-02-12 | 2026-02-17 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award deriv | 2026-02-12 | 2026-02-17 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award deriv | 2026-02-12 | 2026-02-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Cox John | CEO & President | A Award deriv | 2026-02-12 | 2026-02-17 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Lucera Erick | Chief Financial Officer | A Award | 2026-02-12 | 2026-02-17 | 65,000 | — | $0 | 131,100 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award | 2026-02-12 | 2026-02-17 | 60,000 | — | $0 | 154,729 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award | 2026-02-12 | 2026-02-17 | 85,000 | — | $0 | 172,510 | SEC↗ |
| Cox John | CEO & President | A Award | 2026-02-12 | 2026-02-17 | 180,000 | — | $0 | 376,877 | SEC↗ |
| Karnani Vikram | Director | A Award deriv | 2025-12-22 | 2025-12-23 | 59,665 | — | $0 | 59,665 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2025-12-05 | 2025-12-05 | 144 | $20.72 | $3.0K | 94,729 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2025-12-05 | 2025-12-05 | 880 | $20.72 | $18.2K | 87,510 | SEC↗ |
| Cox John | CEO & President | S Sale | 2025-12-05 | 2025-12-05 | 2,662 | $20.72 | $55.2K | 196,877 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2025-10-01 | 2025-10-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2025-09-05 | 2025-09-08 | 873 | $13.41 | $11.7K | 88,390 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2025-09-05 | 2025-09-08 | 144 | $13.41 | $1.9K | 94,873 | SEC↗ |
| Cox John | CEO & President | S Sale | 2025-09-05 | 2025-09-09 | 2,640 | $13.41 | $35.4K | 199,539 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2025-09-04 | 2025-09-08 | 3,552 | $13.27 | $47.1K | 89,263 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2025-09-04 | 2025-09-08 | 894 | $13.27 | $11.9K | 95,017 | SEC↗ |
| Cox John | CEO & President | A Award deriv | 2025-07-16 | 2025-07-18 | 197,285 | — | $0 | 197,285 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award deriv | 2025-07-16 | 2025-07-18 | 65,110 | — | $0 | 65,110 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award deriv | 2025-07-16 | 2025-07-18 | 51,255 | — | $0 | 51,255 | SEC↗ |
| Cox John | CEO & President | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 202,179 | SEC↗ |
| Cox John | CEO & President | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 222,179 | SEC↗ |
| Cox John | CEO & President | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 212,179 | SEC↗ |
| Cox John | CEO & President | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 232,179 | SEC↗ |
| Cox John | CEO & President | P Buy | 2025-07-14 | 2025-07-15 | 100,000 | $9.11 | $911.0K | 242,179 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2025-06-05 | 2025-06-06 | 146 | $13.35 | $1.9K | 95,911 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2025-06-05 | 2025-06-06 | 1,342 | $13.35 | $17.9K | 92,815 | SEC↗ |
| Cox John | CEO & President | S Sale | 2025-06-05 | 2025-06-06 | 4,060 | $13.35 | $54.2K | 142,179 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Incerti Carlo | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Kersten Dirk | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rhodes Jason P | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lucera Erick | Chief Financial Officer | A Award deriv | 2025-03-31 | 2025-04-01 | 214,500 | — | $0 | 214,500 | SEC↗ |
| Lucera Erick | Chief Financial Officer | A Award | 2025-03-31 | 2025-04-01 | 66,100 | — | $0 | 66,100 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | S Sale | 2025-03-13 | 2025-03-13 | 143 | $12.12 | $1.7K | 96,057 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2025-03-11 | 2025-03-13 | 2,153 | $11.38 | $24.5K | 195,840 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2025-03-11 | 2025-03-13 | 1,343 | $11.38 | $15.3K | 122,330 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2025-03-05 | 2025-03-07 | 1,094 | $11.83 | $12.9K | 197,993 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2025-03-05 | 2025-03-07 | 917 | $11.83 | $10.8K | 123,673 | SEC↗ |
| Cox John | CEO & President | S Sale | 2025-03-05 | 2025-03-07 | 4,061 | $11.83 | $48.0K | 146,239 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | S Sale | 2025-03-05 | 2025-03-07 | 1,343 | $11.83 | $15.9K | 94,157 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2025-02-18 | 2025-02-18 | 2,488 | $13.95 | $34.7K | 124,590 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2025-02-18 | 2025-02-25 | 2,598 | $13.95 | $36.2K | 199,087 | SEC↗ |
| Rhodes Jason P | Director | A Award | 2025-01-27 | 2025-01-29 | 1,111,111 | $13.50 | $15.00M | 1,958,427 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-12-11 | 2024-12-11 | 1,455 | $28.12 | $40.9K | 127,078 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2024-12-11 | 2024-12-11 | 2,334 | $28.12 | $65.6K | 201,685 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-09 | 2024-12-10 | 34,437 | $29.18 | $1.00M | 5,400,545 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-06 | 2024-12-10 | 101,675 | $29.34 | $2.98M | 5,434,982 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-05 | 2024-12-06 | 3,806 | $29.05 | $110.6K | 5,536,657 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | A Award deriv | 2024-12-04 | 2024-12-06 | 62,400 | — | $0 | 62,400 | SEC↗ |
| Cox John | CEO & President | A Award deriv | 2024-12-04 | 2024-12-06 | 232,100 | — | $0 | 232,100 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award deriv | 2024-12-04 | 2024-12-06 | 76,600 | — | $0 | 76,600 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | A Award deriv | 2024-12-04 | 2024-12-06 | 52,300 | — | $0 | 52,300 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award deriv | 2024-12-04 | 2024-12-06 | 60,300 | — | $0 | 60,300 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | A Award | 2024-12-04 | 2024-12-06 | 27,400 | — | $0 | 204,019 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | A Award | 2024-12-04 | 2024-12-06 | 39,100 | — | $0 | 176,619 | SEC↗ |
| Cox John | CEO & President | A Award | 2024-12-04 | 2024-12-06 | 145,300 | — | $0 | 150,300 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award | 2024-12-04 | 2024-12-06 | 48,000 | — | $0 | 95,500 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | A Award | 2024-12-04 | 2024-12-06 | 32,700 | — | $0 | 128,533 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-04 | 2024-12-06 | 135,039 | $29.39 | $3.97M | 5,540,463 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award | 2024-12-04 | 2024-12-06 | 37,800 | — | $0 | 96,200 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-03 | 2024-12-04 | 29,732 | $29.05 | $863.7K | 5,675,502 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-02 | 2024-12-04 | 79,973 | $29.66 | $2.37M | 5,706,462 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-12-02 | 2024-12-04 | 1,228 | $30.37 | $37.3K | 5,705,234 | SEC↗ |
| Incerti Carlo | Director | M Exercise deriv | 2024-11-18 | 2024-11-18 | 16,500 | — | $0 | 22,693 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2024-11-18 | 2024-11-18 | 2,856 | $28.20 | $80.5K | 137,519 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-11-18 | 2024-11-18 | 2,735 | $28.20 | $77.1K | 95,833 | SEC↗ |
| Incerti Carlo | Director | S Sale | 2024-11-18 | 2024-11-18 | 16,500 | $28.73 | $474.0K | 0 | SEC↗ |
| Incerti Carlo | Director | M Exercise | 2024-11-18 | 2024-11-18 | 16,500 | $8.69 | $143.4K | 16,500 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-11-14 | 2024-11-15 | 8,929 | $32.82 | $293.0K | 5,786,435 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2024-11-14 | 2024-11-18 | 72 | $33.10 | $2.4K | 847,316 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2024-11-14 | 2024-11-18 | 123 | $33.10 | $4.1K | 1,458,568 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2024-11-14 | 2024-11-18 | 4 | $33.10 | $132 | 15,962 | SEC↗ |
| Rhodes Jason P | Director | S Sale | 2024-11-14 | 2024-11-18 | 583 | $33.10 | $19.3K | 5,697,508 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-11-13 | 2024-11-15 | 10,803 | $35.24 | $380.7K | 62,301 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-21 | 2024-10-22 | 121 | $35.06 | $4.2K | 73,104 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-18 | 2024-10-22 | 13,414 | $35.16 | $471.6K | 73,225 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-17 | 2024-10-18 | 13,013 | $35.17 | $457.7K | 86,639 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-16 | 2024-10-18 | 23,671 | $35.35 | $836.8K | 99,652 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-03 | 2024-10-07 | 5,441 | $35.13 | $191.1K | 123,323 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-02 | 2024-10-03 | 21,518 | $35.38 | $761.3K | 128,764 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-10-01 | 2024-10-03 | 8,423 | $35.16 | $296.2K | 150,282 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-30 | 2024-10-01 | 29,007 | $35.47 | $1.03M | 160,640 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-30 | 2024-10-01 | 1,935 | $36.02 | $69.7K | 158,705 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-27 | 2024-10-01 | 32 | $35.00 | $1.1K | 189,647 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-26 | 2024-09-27 | 1,260 | $35.29 | $44.5K | 189,679 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-25 | 2024-09-27 | 2,357 | $35.06 | $82.6K | 190,939 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-23 | 2024-09-24 | 4,610 | $36.33 | $167.5K | 193,296 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-23 | 2024-09-24 | 36,221 | $35.19 | $1.27M | 197,906 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-20 | 2024-09-24 | 78,940 | $36.45 | $2.88M | 234,598 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-20 | 2024-09-24 | 471 | $37.01 | $17.4K | 234,127 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-19 | 2024-09-20 | 50,972 | $36.41 | $1.86M | 313,538 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-19 | 2024-09-20 | 27,767 | $35.74 | $992.4K | 364,510 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2024-09-18 | 2024-09-19 | 2,339 | $34.55 | $80.8K | 140,375 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-09-18 | 2024-09-19 | 1,390 | $34.55 | $48.0K | 98,568 | SEC↗ |
| HIGH SUSANNA GATTI | Chief Operating Officer | S Sale | 2024-09-18 | 2024-09-19 | 4,636 | $34.41 | $159.5K | 131,636 | SEC↗ |
| HIGH SUSANNA GATTI | Chief Operating Officer | S Sale | 2024-09-18 | 2024-09-19 | 4,340 | $34.41 | $149.3K | 136,272 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-18 | 2024-09-20 | 1,554 | $35.03 | $54.4K | 392,277 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-17 | 2024-09-18 | 3,272 | $35.13 | $114.9K | 393,831 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-16 | 2024-09-18 | 1,320 | $35.04 | $46.3K | 397,103 | SEC↗ |
| HIGH SUSANNA GATTI | Chief Operating Officer | S Sale | 2024-09-11 | 2024-09-11 | 2,722 | $31.89 | $86.8K | 140,612 | SEC↗ |
| HIGH SUSANNA GATTI | Chief Operating Officer | S Sale | 2024-09-11 | 2024-09-11 | 2,548 | $31.89 | $81.3K | 143,334 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-09-11 | 2024-09-11 | 1,468 | $31.89 | $46.8K | 99,958 | SEC↗ |
| Beskrovnaya Oxana | Chief Scientific Officer | S Sale | 2024-09-11 | 2024-09-11 | 2,161 | $31.89 | $68.9K | 142,714 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 34,833 | — | $0 | 742 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 3,353 | — | $0 | 0 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 6,502 | — | $0 | 0 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 16,696 | — | $0 | 8,348 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 18,750 | — | $0 | 26,250 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 6,552 | — | $0 | 28,394 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise deriv | 2024-09-06 | 2024-09-10 | 29,792 | — | $0 | 25,208 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 6,502 | $5.54 | $36.0K | 117,524 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 16,696 | $13.12 | $219.1K | 172,406 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 34,833 | $19.00 | $661.8K | 155,710 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 3,353 | $5.54 | $18.6K | 120,877 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 29,792 | $8.58 | $255.6K | 202,198 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-09-06 | 2024-09-10 | 124,374 | $32.14 | $4.00M | 103,126 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | S Sale | 2024-09-06 | 2024-09-10 | 1,700 | $32.63 | $55.5K | 101,426 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 18,750 | $10.72 | $201.0K | 220,948 | SEC↗ |
| Scalzo Richard William | SVP, Head of Finance & Admin | M Exercise | 2024-09-06 | 2024-09-10 | 6,552 | $10.88 | $71.3K | 227,500 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-09-05 | 2024-09-09 | 1,577 | $35.03 | $55.2K | 398,423 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| Cox John | CEO & President | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award deriv | 2024-09-03 | 2024-09-03 | 185,300 | — | $0 | 185,300 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award deriv | 2024-09-03 | 2024-09-03 | 150,300 | — | $0 | 150,300 | SEC↗ |
| Friedl-Naderer Johanna | Chief Commercial Officer | A Award | 2024-09-03 | 2024-09-03 | 58,400 | — | $0 | 58,400 | SEC↗ |
| Kerr Douglas | Chief Medical Officer | A Award | 2024-09-03 | 2024-09-03 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-30 | 2024-09-04 | 6,204 | $46.01 | $285.4K | 400,000 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-30 | 2024-09-04 | 25,096 | $45.49 | $1.14M | 406,204 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-29 | 2024-08-30 | 10,768 | $45.81 | $493.3K | 431,300 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-29 | 2024-08-30 | 45,640 | $45.19 | $2.06M | 442,068 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-28 | 2024-08-30 | 16,386 | $44.41 | $727.7K | 549,175 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-28 | 2024-08-30 | 61,467 | $44.94 | $2.76M | 487,708 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-27 | 2024-08-28 | 65,403 | $44.28 | $2.90M | 565,561 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-26 | 2024-08-28 | 11,534 | $45.79 | $528.1K | 630,964 | SEC↗ |
| Kersten Dirk | Director | S Sale | 2024-08-26 | 2024-08-28 | 77,963 | $45.23 | $3.53M | 642,498 | SEC↗ |